Trustmark National Bank Trust Department’s AstraZeneca AZN Stock Holding History

Trustmark National Bank Trust Department’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Buy	+5,971	New	+$1.12M	0.07%	161
2019 Q2	–	Sell	-205	Closed	-$17K	–	579
2019 Q1	$17K	Hold	205	–	–	﹤0.01%	427
2018 Q4	$16K	Hold	205	–	–	﹤0.01%	420
2018 Q3	$16K	Buy	+205	New	+$15.5K	﹤0.01%	448
2018 Q2	–	Sell	-5,253	Closed	-$367K	–	235
2018 Q1	$367K	Sell	5,253 -1,750	-25%	-$121K	0.04%	195
2017 Q4	$486K	Sell	7,003 -96	-1%	-$6.47K	0.05%	187
2017 Q3	$481K	Buy	7,099 +876	+14%	+$55.3K	0.06%	181
2017 Q2	$424K	Hold	6,223	–	–	0.05%	197
2017 Q1	$387K	Buy	6,223 +2,404	+63%	+$140K	0.05%	196
2016 Q4	$209K	Hold	3,819	–	–	0.03%	239
2016 Q3	$251K	Buy	+3,819	New	+$250K	0.03%	229

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trustmark National Bank Trust Department's AZN Position: Q2 2026 in Review

Trustmark National Bank Trust Department opened a new position in AstraZeneca (AZN) in Q2 2026: 5,971 shares worth $1.13M. The stake represents 0.07% of the portfolio and ranks #161 among its holdings. This is a return to the name: Trustmark National Bank Trust Department previously reported a position in AZN as recently as Q1 2019.

Trustmark National Bank Trust Department first reported a position in AZN in Q3 2016 and has held it in 11 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Trustmark National Bank Trust Department held 5,971 shares of AstraZeneca worth $1.13M as of Q2 2026.
AstraZeneca was a new Trustmark National Bank Trust Department position in Q2 2026.
AstraZeneca made up 0.07% of Trustmark National Bank Trust Department's portfolio in Q2 2026, its #161 holding.
Trustmark National Bank Trust Department first reported a position in AstraZeneca in Q3 2016 and has held it in 11 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Trustmark National Bank Trust Department's 13F filing for Q2 2026, filed 12 Aug 2026.